P3 Health Partners Inc. Reaffirmed Earnings Guidance for the full-year ending December 31, 2024. For the year, the company Reaffirming revenue from $1.45 billion to $1.55 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.502 USD | +3.02% | -14.92% | -64.40% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.40% | 60.05M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- PIII Stock
- News P3 Health Partners Inc.
- P3 Health Partners Inc. Reaffirms Earnings Guidance for the full-year ending December 31, 2024